Molluscum Contagiosum | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

47 results for “Molluscum Contagiosum”

Trials

View all 28 →

A Phase 3 Molluscum Contagiosum Efficacy and Safety Study

891 participants · First posted Sep 2, 2020

Picato for the Treatment of Molluscum Contagiosum in Immunocompromised Patients

First posted Nov 8, 2017

A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum

110 participants · First posted Mar 13, 2017

Drugs

VDMC-7269

Cantharidin(Cantharone Plus, Ycanth)

Conditions: Molluscum Contagiosum, Periungual Warts +2 more

C₁₀H₁₂O₄ · Rx

News

View all 17 →

FDA Approves Verrica's Ycanth, First Treatment for Molluscum Contagiosum

Pelthos Therapeutics Launches ZELSUVMI, First FDA-Approved At-Home Treatment for Molluscum Contagiosum

Channel Therapeutics and Pelthos Therapeutics Merge to Accelerate Zelsuvmi Launch for Molluscum Contagiosum

Page 1 of 5